Efficacy and safety of a new kappa-opioid receptor agonist for the treatment of uremic pruritus.
Delmez
James A
JA
Chromalloy American Kidney Center, Washington University School of Medicine, St Louis, MO 63110, USA. jdelmez@imgate.wustl.edu
D006801:Humans; D009019:Morphinans / Q000627:therapeutic use*; D011537:Pruritus / Q000188:drug therapy* / Q000209:etiology*; D017473:Receptors, Opioid, kappa / Q000819:agonists*; D013141:Spiro Compounds / Q000627:therapeutic use*; D014511:Uremia / Q000150:complications*
D009019:Morphinans; D017473:Receptors, Opioid, kappa; D013141:Spiro Compounds; C111212:TRK 820